Microbial evolution (Communication arising): Antitoxin vaccines and pathogen virulence

Sylvain Gandon, Margaret J. Mackinnon, Sean Nee, Andrew F. Read

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Soubeyrand and Plotkin question our contention that antitoxin vaccines may select for greater pathogen virulence, arguing that this has not been borne out in real-life cases of diphtheria and pertussis, in which the widespread use of antitoxin vaccines has led to a reduced incidence of severe disease. They explain this success in terms of direct effects by the toxin on transmission that are both beneficial and costly. They argue that antitoxin vaccines have relieved the pathogen of the cost of high virulence due to host mortality (as we do too), but that these vaccines also maintain the metabolic cost of producing the toxin, helping natural selection to weed out the toxin producers.

Original languageEnglish (US)
Number of pages1
JournalNature
Volume417
Issue number6889
DOIs
StatePublished - Jun 6 2002

Fingerprint

antitoxins
virulence
vaccines
toxins
pathogens
natural selection
weeds
incidence

All Science Journal Classification (ASJC) codes

  • General

Cite this

Gandon, Sylvain ; Mackinnon, Margaret J. ; Nee, Sean ; Read, Andrew F. / Microbial evolution (Communication arising) : Antitoxin vaccines and pathogen virulence. In: Nature. 2002 ; Vol. 417, No. 6889.
@article{0eeb686fb7464b4795f98941d1d1b62a,
title = "Microbial evolution (Communication arising): Antitoxin vaccines and pathogen virulence",
abstract = "Soubeyrand and Plotkin question our contention that antitoxin vaccines may select for greater pathogen virulence, arguing that this has not been borne out in real-life cases of diphtheria and pertussis, in which the widespread use of antitoxin vaccines has led to a reduced incidence of severe disease. They explain this success in terms of direct effects by the toxin on transmission that are both beneficial and costly. They argue that antitoxin vaccines have relieved the pathogen of the cost of high virulence due to host mortality (as we do too), but that these vaccines also maintain the metabolic cost of producing the toxin, helping natural selection to weed out the toxin producers.",
author = "Sylvain Gandon and Mackinnon, {Margaret J.} and Sean Nee and Read, {Andrew F.}",
year = "2002",
month = "6",
day = "6",
doi = "10.1038/417610b",
language = "English (US)",
volume = "417",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "6889",

}

Microbial evolution (Communication arising) : Antitoxin vaccines and pathogen virulence. / Gandon, Sylvain; Mackinnon, Margaret J.; Nee, Sean; Read, Andrew F.

In: Nature, Vol. 417, No. 6889, 06.06.2002.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Microbial evolution (Communication arising)

T2 - Antitoxin vaccines and pathogen virulence

AU - Gandon, Sylvain

AU - Mackinnon, Margaret J.

AU - Nee, Sean

AU - Read, Andrew F.

PY - 2002/6/6

Y1 - 2002/6/6

N2 - Soubeyrand and Plotkin question our contention that antitoxin vaccines may select for greater pathogen virulence, arguing that this has not been borne out in real-life cases of diphtheria and pertussis, in which the widespread use of antitoxin vaccines has led to a reduced incidence of severe disease. They explain this success in terms of direct effects by the toxin on transmission that are both beneficial and costly. They argue that antitoxin vaccines have relieved the pathogen of the cost of high virulence due to host mortality (as we do too), but that these vaccines also maintain the metabolic cost of producing the toxin, helping natural selection to weed out the toxin producers.

AB - Soubeyrand and Plotkin question our contention that antitoxin vaccines may select for greater pathogen virulence, arguing that this has not been borne out in real-life cases of diphtheria and pertussis, in which the widespread use of antitoxin vaccines has led to a reduced incidence of severe disease. They explain this success in terms of direct effects by the toxin on transmission that are both beneficial and costly. They argue that antitoxin vaccines have relieved the pathogen of the cost of high virulence due to host mortality (as we do too), but that these vaccines also maintain the metabolic cost of producing the toxin, helping natural selection to weed out the toxin producers.

UR - http://www.scopus.com/inward/record.url?scp=84984757424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984757424&partnerID=8YFLogxK

U2 - 10.1038/417610b

DO - 10.1038/417610b

M3 - Article

AN - SCOPUS:84984757424

VL - 417

JO - Nature

JF - Nature

SN - 0028-0836

IS - 6889

ER -